Skip to main content
. Author manuscript; available in PMC: 2018 Mar 8.
Published in final edited form as: Nucl Med Biol. 2013 Sep 24;40(8):994–999. doi: 10.1016/j.nucmedbio.2013.08.005

Table 3.

Percent of Pretreatment Tumor Volume (TV) and Body Weight (BW) of mice bearing BT474 Xenografts with and without (n=8) Doxorubicin Treatment (n=8)

Pre-treatment measures Post treatment percentages
Variables Week 1a Week 3b Week 5b Week 7b
Treated mouse weight 100% (23.46±2.2 g) 103.4±7.6% 107.9 ±6.2% 102.9±5.8%
Treated tumor volume 100% (24.35±2.7 mm3) 114.2±61.8% 105.9±59.6% 80.36±46.5%
Control mouse weight 100% (25.25±4.3 g) 100.1±4.3% 102.6±5.7% 102.7±7.4%
Control tumor volume 100% (24.35±3.4 mm3) 144.7±64.4% 162.7±80.5% 213.2±77.7%
a

first week TV and BW before treatment were considered to be 100%, relative to post-treatment values.

b

percentage of 1st week pretreatment TV or BW